medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Number 3

<< Back Next >>

Ann Hepatol 2012; 11 (3)

Hepatitis B virus prevalence and vaccination response in health care workers and students at the Federal University of Bahia, Brazil

Carvalho P, Schinoni MI, Andrade J, Vasconcelos RMA, Marques P, Meyer R, Araújo A, Menezes T, Oliveira C, Sousa MR, Sousa ML, Leal JC, Matos B, Schaer R, Simões JM, Freire SM, Paraná R

Language: English
References: 33
Page: 330-337
PDF size: 96.81 Kb.


ABSTRACT

Background and rationale for the study. Hepatitis B (HB) is one of the most prevalent occupational infections in health attendance environments. According to the Brazil Ministry of Health, health professionals must be vaccinated against the hepatitis B virus (HBV) and provide laboratory proof of immunization. Aims. To evaluate the seroprevalence of HBV infection and to analyze the response to vaccine by measuring serum antibodies against HBV surface antigen (anti-HBs) levels in a sample of students and health professionals at the Federal University of Bahia. Results. As part of this cross-sectional study, a campaign against occupational HB was launched in 2007 and vaccination and blood samples were collected for analysis of the following serological markers: HBV surface antigen (HBsAg) and anti-HBs (measured by enzyme-linked immunoassay) and total antibodies against HBV core antigen (anti-HBc). The study sample comprised 766 people. Global seropositivity for HBV was 1.7%: 0.5% in the students and 8.8% in the professionals. In a group of volunteers, a serological profile compatible with postvaccine immunity was shown by 95% of volunteers with proof of vaccination and by 81.8% of volunteers without proof of vaccination. Conclusions. In conclusion, this study shows that it is important to promote vaccination campaigns and improve knowledge and awareness about HB among health care workers and higher education students.


REFERENCES

  1. World Health Organization (WHO). Hepatitis B Factsheet No 204. Revised October 2000. Geneva: WHO. Available at: http://who.int/inf-fs/en/fact204.html [Accessed 24 June 2008].

  2. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, et al. A comprehensive immunization strategy can eliminate transmission of hepatitis B virus infection in the United States. Recommendation of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of infants, children and adolescents. MMWR Recomm Rep 2005; 54(RR-16): 1-31.

  3. Ferreira MS. Diagnoses and treatment of hepatitis B. Rev Soc Bras Med Trop 2000; 4: 389-400.

  4. Sociedade Brasileira de Infectologia (SBI). I Consenso da Sociedade Brasileira de Infectologia para Diagnóstico e Manuseio da Hepatite B (e Delta). Braz J Infect Dis 2006; (Suppl. 10): 6-10.

  5. Conte VP. Hepatocelullar carcinoma. Part 1: general considerations and diagnoses. Arq Gastroenterol 2000; 37(1): 58-67.

  6. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocarcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet 1981; 2: 1129-33.

  7. Ministério da Saúde do Brasil. Guia de Vigilância Epidemiológica. Brasília, Ministério da Saúde; 2005.

  8. Braga WSM, Brasil LM, Souza RAB, Melo MS, Rosas MDG, Castilho MC, Fonseca JCF. Prevalence of hepatitis B virus (HBV) and hepatitis D virus (HDV) Infections in Lábrea, Purus River Basin, Western Brazilian Amazon. Epidemiologia e Serviços de Saúde 2004; 13(1): 35-46.

  9. Fernandes JV, Braz RFS, Neto FVA, Silva MA, Costa NF, Ferreira AM. Prevalence of serologic markers of the hepatitis B virus in hospital personnel. Revista de Saúde Pública 1999; 33(2): 122-8.

  10. Focaccia R, Veronesi R, Takeda AK, Kimura RT, Focaccia MTC. Risk of infection by hepatitis B virus in hospital personnel and immunity naturally acquired. Rev Assoc Med Bras 1986; 32: 111-4.

  11. Byrne EB. Viral hepatitis: an occupational hazard of medical personnel. J Am Med Assoc 1966; 195: 118-20.

  12. Centers for Disease Control and Prevention. Exposure to Blood-What Healthcare Personnel Need to Know 2003. Available at: http://bookstore.phf.org [Accessed 2 June 2008].

  13. El Khouri M, Santos VA. Hepatitis B: epidemiological, immunological, and serological considerations emphasizing mutation. Rev Hosp Clin 2004; 59(4): 216-24.

  14. Ministério da Saúde do Brasil, Secretaria de Vigilância em Saúde. Programa Nacional de Imunizações-30 anos. Série C. Projetos e Programas e Relatórios. Brasília: Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica; 2003.

  15. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-5.

  16. Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP); Part 2: Immunization of Adults. MMWR Recomm Rep 2006; 55(No. RR-16): 25.

  17. Ministério da Saúde do Brasil, Fundação Nacional de Saúde. Manual de rede de frio. Brasília: Ministério da Saúde, Fundação Nacional de Saúde; 2001.

  18. Davis JP. Experience with hepatitis A and B vaccines. Am J Med 2005; 118(Suppl. 10A): 7S-15.

  19. Ministério da Saúde do Brasil, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica, Programa Nacional de Imunizações. Manual dos Centros de Referência Para Imunobiológicos Especiais, Brasília, Ministério da Saúde; 2006. Available from: http: // www. infectologia. org.br /anexos /MS_PNI_ manual %20CRIE%202006. pdf [Accessed 8 September 2008].

  20. Ministério da Saúde do Brasil, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. Plano Nacional de Prevenção e Controle das Hepatites Virais. Brasília, Ministério da Saúde, Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica; 2006.

  21. Silveira TR, Fonseca JC, Rivera L, Fay OH, Tapia R, Santos JI, Urdeneta E, et al. Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica 1999; 6(6): 378-83.

  22. Parana R. Manual de biossegurança no diagnóstico e tratamento de infecções virais-viroses hepatotrópicas/hepatites. In: BAHIA. Secretaria de Saúde. Manual de Biossegurança para as Áreas das Ciências da Saúde e Biológicas; 2002, p. 481-502.

  23. Clemens SAC, Fonseca JC, Azevedo T, Cavalcanti A, Silveira TR, Castilho MC, Clemens R. Hepatitis A and hepatitis B seroprevalence in four centers in Brazil. Rev Soc Bras Med Trop 2000; 33(1): 1-10.

  24. Lopes CLR, Martins RMB, Araújo TS, Silva SA, Maggi PS, Yoshida CFT. Seroepidemiological profile of hepatitis B infection in staff of hemodialysis units of Goiânia-Goiás, Central Brazil. Rev Soc Bras Med Trop 2001; 34(6): 543-8.

  25. Braga A, Marques P, Andrade J, Schinoni MI, Menezes I, Duque A, Lemaire DC, et al. Hepatitis B virus seropreva lence and anti-HBS serum response in dental surgeons in salvador-Bahia. Revista Baiana de Saúde Pública 2008; 32(1): 7-17.

  26. Barrigar DL, Flagel DC, Upshur RE. Hepatitis B virus infected physicians and disclosure of transmission risks to patients: a critical analysis. BMC Med Ethics 2001; 2: E4.

  27. Pan CQ, Zhang JX. Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci 2005; 2(1): 36-40.

  28. Secretaria Municipal de Saúde do Rio de Janeiro, Gerência de DST/AIDS, Universidade Federal do RJ, Serviço DIP do HUCFF, Departamento de HIV/AIDS, Organização Mundial de Saúde Genebra, Suíça e MS/SVS/DEVEP. Programa Nacional para a Prevenção e o Controle das Hepatites Virais; 2002. Available from:http//bvsms.saude.gov.br/bvs/aids/ publicacoes/manual_acidentes.pdf [Accessed 21 July 2008].

  29. Pasko MT, Beam JR, TR. Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine. Am J Public Health 1990; 80(5): 590-3.

  30. Nizama JC. Grado de imunidad humoral y factores asociados a la respuesta a la vacunación contra el vírus de la Hepatitis B em el personal de salud del Hospital Nacional Cese-Essalud, Arequipa (Septiembre 1995–Marzo 2002). Rev Gastroenterol Peru 2005; 25(2): 1-30.

  31. Martins AMEBL, Barreto SM. Hepatitis B vaccination among dentists. Rev Saúde Pública 2003; 37(3): 333-8.

  32. Salgado MF. Vacinação contra a hepatite B em trabalhadores da saúde. Dissertação (mestrado), Escola de Enfermagem, São Paulo [dissertation]; 2001.

  33. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-preventable Diseases. 10th. Ed. Atlanta, Public Health Foundation; 2008.




2020     |     www.medigraphic.com